Valvular & structural heart diseaseCohort study
Impact of Valve Frame Height on Percutaneous Coronary Intervention (PCI) Outcomes After Transcatheter Aortic Valve Replacement (TAVR)
- Retrospective cohort study
- multicentre registry (REVIVAL-PCI)
- entropy-balance weighted Cox regression
Authors' conclusion
In current practice, long-term outcomes after PCI in TAVR patients do not appear to be significantly different between those receiving SFVs and TFVs.
Study context
- Population
- Patients undergoing PCI after TAVR, 21 European centres, 2008–2023
- Participants
- 441 patients
- Exposure
- Short-framed vs tall-framed transcatheter aortic valves
- SFVn = 230
- TFVn = 211reference
- Outcome
- major adverse cardiovascular events, defined as the composite of cardiovascular death, myocardial infarction, or stroke
- Follow-up
- 4-year incidence
Main finding
As reported in the abstract
Hazard ratio
1.04
95% CI 0.71–1.52
P = 0.846
By group
SFV vs TFV
HR 1.04 (95% CI 0.71–1.52); P = 0.846
Observational data: associations, not effects.
Original publication
Impact of Valve Frame Height on PCI Outcomes After TAVR. JACC Cardiovasc Interv. Published 25 October 2025. doi:10.1016/j.jcin.2025.09.030
Summarised from the published abstract; every number is checked against it